Recognition of ribonucleoprotein (RNP) substrate by the poly(A) exosome targeting (PAXT) complex
Project Number5K99CA267555-02
Contact PI/Project LeaderPARK, MI SEUL
Awardee OrganizationSLOAN-KETTERING INST CAN RESEARCH
Description
Abstract Text
PROJECT SUMMARY AND ABSTRACT
RNA surveillance pathways regulate the quality of cellular RNAs and their abundance. In the nucleus, aberrant,
misfolded, or defective RNAs are degraded primarily by the 3¢-5¢ decay machinery that includes the RNA
exosome, a multi-subunit protein complex that catalyzes 3¢ to 5¢ RNA degradation. The nuclear RNA exosome
targeting substrate is mediated by several protein complexes containing the MTR4 helicase. These include the
nuclear exosome targeting (NEXT) complex and the poly(A) exosome targeting (PAXT) connection which lie
upstream of the RNA exosome. The RNA exosome mutants or overexpressed cofactors contribute to
numerous human diseases, including cancer. Although several studies illuminated the human exosome
structure and functions, there are limited studies on how human NEXT and PAXT engage and prepare their
substrates for their delivery to the RNA exosome.
This research will engage biochemical, structural, and functional approaches to characterize the core
PAXT complex (Aim 1) and determine how substrates are recognized as ribonucleoprotein (RNP) complexes
through nuclear cap-binding complex and poly(A) binding protein (Aim 2). I will leverage the use of reagents
and skills developed in Aim 1 and Aim 2 during the K99 phase to investigate microRNA (miRNA) processing
and turnover by PAXT connection (Aim 3). The outcome of this study will provide novel insights into the
molecular mechanism of target RNP recognition by PAXT and their interaction with the RNA exosome in RNA
decay pathways. Moreover, the study will be expanding to miRNA biogenesis. As RNA decay pathways and
miRNA biogenesis play a fundamental role in gene regulation and cancer, this study can impact human health
and the NCI mission to develop scientific knowledge and support all people to live longer and healthier.
This proposal describes a comprehensive training plan to develop my academic career by investigating
how PAXT recognizes its RNP substrates to stimulate downstream RNA decay and primary miRNA
processing. The purpose of this award is to encourage and prepare my independent research program, and I
will use this period to advance my scientific knowledge and professional skills. During the K99 phase, I will
employ biochemical approaches to reconstitute the PAXT connection with its target and combine them with
cryo-electron microscopy under Dr. Christopher D. Lima’s mentoring. That will extend my technical repertoire
and biological knowledge in RNA biology, cancer biology, and structural biology for future research. Also,
Memorial Sloan Kettering Cancer Center will provide institutional support, including laboratory research
resources, an open scientific environment, and career development to achieve my goals.
Public Health Relevance Statement
PROJECT NARRATIVE
RNA surveillance pathways monitor the quality of cellular RNAs and regulate them by degradation. The
nuclear RNA exosome and its cofactors contribute to catalyzing 3¢ to 5¢ processing and degradation of RNAs in
the surveillance pathways. This proposal seeks to study the upstream factors of the RNA exosome in RNA
decay pathways and miRNA processing through structural, biochemical, and functional approaches, which
provide valuable insights into the nuclear RNA surveillance mechanisms underlying defects associated with
human diseases, such as cancer.
No Sub Projects information available for 5K99CA267555-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K99CA267555-02
Patents
No Patents information available for 5K99CA267555-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K99CA267555-02
Clinical Studies
No Clinical Studies information available for 5K99CA267555-02
News and More
Related News Releases
No news release information available for 5K99CA267555-02
History
No Historical information available for 5K99CA267555-02
Similar Projects
No Similar Projects information available for 5K99CA267555-02